These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 32144340)
1. Evaluation of Radiation dosimetry of Zhang J; Zhang J; Xu X; Lu L; Hu S; Liu C; Cheng J; Song S; Zhang Y; Shi LQ Sci Rep; 2020 Mar; 10(1):4179. PubMed ID: 32144340 [TBL] [Abstract][Full Text] [Related]
2. Dosimetry estimation and preliminary clinical application of [ Yang H; Gao Z; Xu X; Liu C; Hu S; Zhang J; Song S Ann Nucl Med; 2023 Jan; 37(1):60-69. PubMed ID: 36346503 [TBL] [Abstract][Full Text] [Related]
3. Radiation Dosimetry of Urbán S; Meyer C; Dahlbom M; Farkas I; Sipka G; Besenyi Z; Czernin J; Calais J; Pávics L J Nucl Med; 2021 Aug; 62(8):1075-1081. PubMed ID: 33277398 [No Abstract] [Full Text] [Related]
5. Xu X; Zhang J; Hu S; He S; Bao X; Ma G; Luo J; Cheng J; Zhang Y Nucl Med Biol; 2017 May; 48():69-75. PubMed ID: 28273495 [TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
7. Clinical translation of a PSMA inhibitor for Ferro-Flores G; Luna-Gutiérrez M; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Orocio-Rodríguez E; Davanzo J; García-Pérez FO Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT. Lawal IO; Ankrah AO; Mokgoro NP; Vorster M; Maes A; Sathekge MM Prostate; 2017 Aug; 77(11):1205-1212. PubMed ID: 28649735 [TBL] [Abstract][Full Text] [Related]
9. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging. Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen. Mosayebnia M; Hajimahdi Z; Beiki D; Rezaeianpour M; Hajiramezanali M; Geramifar P; Sabzevari O; Amini M; Hatamabadi D; Shahhosseini S Bioorg Chem; 2020 Jun; 99():103743. PubMed ID: 32217372 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and Evaluation of Lu K; Zhang C; Zhang Z; Kuo HT; Colpo N; Bénard F; Lin KS Molecules; 2023 Jun; 28(13):. PubMed ID: 37446782 [TBL] [Abstract][Full Text] [Related]
12. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer. Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024 [TBL] [Abstract][Full Text] [Related]
18. Relationship between PSA kinetics and Tc-99m HYNIC PSMA SPECT/CT detection rates of biochemical recurrence in patients with prostate cancer after radical prostatectomy. Liu C; Zhu Y; Su H; Xu X; Zhang Y; Ye D; Hu S Prostate; 2018 Dec; 78(16):1215-1221. PubMed ID: 30027591 [TBL] [Abstract][Full Text] [Related]
19. Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy. Zechmann CM; Afshar-Oromieh A; Armor T; Stubbs JB; Mier W; Hadaschik B; Joyal J; Kopka K; Debus J; Babich JW; Haberkorn U Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1280-92. PubMed ID: 24577951 [TBL] [Abstract][Full Text] [Related]